WebDisclosure WebDisclosure
Basculer en Français
10621 Companies
225706 Keywords
154266 Articles
119431 Press releases
Headlines Articles Press releases AL-S Pharma AG Remove
  1. Home
  2. Companies
  3. AL-S Pharma AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/19/2026 at 07:35, 3 months 4 days ago

    AL-S Pharma's AP-101 Shows Promise in ALS Treatment

    Clinical Trial ALS Treatment Phase 2 Data AP-101 SOD1 Targeting
  • BRIEF

    published on 03/19/2026 at 07:35, 3 months 4 days ago

    Le traitement AP-101 d'AL-S Pharma se révèle prometteur dans le traitement de la SLA.

    Essai Clinique Traitement De La SLA Données De La Phase 2 AP-101 Ciblage SOD1
  • PRESS RELEASE

    published on 03/19/2026 at 07:30, 3 months 4 days ago

    Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

    AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression
    ALS Phase 2 Data AP-101 AL-S Pharma AG SOD1
    Logo of AL-S Pharma AG
Accesswire
  • Published on 06/24/2026 at 03:15, 2 hours 4 minutes ago

    Noram Lithium Adopts Semi-Annual Financial Reporting

  • Published on 06/24/2026 at 00:00, 5 hours 19 minutes ago

    Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010

  • Published on 06/23/2026 at 23:45, 5 hours 34 minutes ago

    Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs

  • Published on 06/23/2026 at 23:20, 5 hours 59 minutes ago

    BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption

  • Published on 06/23/2026 at 23:15, 6 hours 4 minutes ago

    EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects

View all ACCESSWIRE
EQS Group
  • Published on 06/24/2026 at 04:00, 1 hour 18 minutes ago

    Shipping edges closer to onboard carbon mineralisation as IMO endorses Shanghai Qiyao Technology Group Co., Ltd. proposals

  • Published on 06/24/2026 at 02:05, 3 hours 13 minutes ago

    FRONTERA AND KUPARI ANNOUNCE COMMENCEMENT OF STRATEGIC SALE PROCESS FOR THE JOINTLY OWNED PIEDRAS VERDES COPPER MINE COMPLEX IN SONORA, MEXICO

  • Published on 06/23/2026 at 22:20, 6 hours 58 minutes ago

    Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership

  • Published on 06/23/2026 at 20:15, 9 hours 4 minutes ago

    EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights

  • Published on 06/23/2026 at 18:59, 10 hours 20 minutes ago

    Holding(s) in Company

View all EQS
Les Echos
  • Published on 06/23/2026 at 19:47, 9 hours 31 minutes ago

    GROUPE SFPI: reorganisation de la Direction Générale

  • Published on 06/23/2026 at 19:47, 9 hours 31 minutes ago

    GROUPE SFPI: General management reorganisation

  • Published on 06/23/2026 at 19:10, 10 hours 8 minutes ago

    GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026

  • Published on 06/23/2026 at 19:10, 10 hours 8 minutes ago

    GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026

  • Published on 06/23/2026 at 18:32, 10 hours 46 minutes ago

    Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy